Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | Director | June 23, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date June 23, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,363 |
Reported balance
After 2026-06-23 transaction · row 1
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 7,697 · Balance 40,363 F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2017 Filed Jun 20, 2017 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 6,472 | $7.78 | $50,352.16 |
DisclosureSEC source: 0001140361-17-025563 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 9,106 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0001140361-17-025563 · doc1.xml · derivative · entry 8 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,457 Underlying: Class A Common Stock · 9,106 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 6,530 | $27.54 | $179,855.79 |
DisclosureSEC source: 0001140361-17-025563 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $27.50 to $27.65. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 2,576 | $27.50 | $70,840.00 |
DisclosureSEC source: 0001140361-17-025563 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,230 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 9,106 | $7.78 | $70,844.68 |
DisclosureSEC source: 0001140361-17-025563 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,255 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · derivative · entry 9 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,563 Underlying: Class A Common Stock · 1,255 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 900 | $27.75 | $24,975.00 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · nonDerivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 355 | $27.50 | $9,762.50 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · nonDerivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,600 Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 1,255 | $7.78 | $9,763.90 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 5,182 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · derivative · entry 8 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,818 Underlying: Class A Common Stock · 5,182 shares Expires 2019-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,740 | $28.03 | $104,844.92 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $28.00 to $28.20. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 1,442 | $27.95 | $40,303.90 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,440 Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:16 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 5,182 | $7.78 | $40,315.96 |
DisclosureSEC source: 0001140361-17-025353 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2017 Filed May 11, 2017 16:29 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $44.47 | $0.00 |
DisclosureSEC source: 0001140361-17-019560 · doc1.xml · derivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Class B Common Stock · 6,000 shares Expires 2027-05-09 Read SEC document |
| May 09, 2017 Filed May 11, 2017 16:29 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001140361-17-019560 · doc1.xml · derivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Class A Common Stock · 36,000 shares Expires 2027-05-09 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.